NCT04652830 Naprapathy Training for Postpartum DRAM Prevention
| NCT ID | NCT04652830 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karolinska Institutet |
| Condition | Diastasis Recti |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2021-03-01 |
| Primary Completion | 2025-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2021-03-01 with a primary completion date of 2025-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A randomised controlled trial with the aim of analysing the effectiveness of a training program intended to prevent symptoms related to DRAM in the postpartum period.
Eligibility Criteria
Inclusion Criteria: * Uni- and multiparous women 3-12 months postpartum * Ability to understand Swedish language * Ability participate in a three months follow-up program * Diastasis of the rectus abdominis muscles \> 3 cm Exclusion Criteria: * Ongoing pregnancy * Age \<18 years or \>50 years * \< 3 months or \>12 months post partum * History of neurologic, musculoskeletal or psychiatric disorders * Interrectal diastasis \< 3 cm
Contact & Investigator
Gabriel Sandblom, Ass Prof
PRINCIPAL INVESTIGATOR
Karolinska Institutet
Frequently Asked Questions
Who can join the NCT04652830 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Diastasis Recti. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04652830 currently recruiting?
Yes, NCT04652830 is actively recruiting participants. Contact the research team at katarina@woxnerud.se for enrollment information.
Where is the NCT04652830 trial being conducted?
This trial is being conducted at Stockholm, Sweden.
Who is sponsoring the NCT04652830 clinical trial?
NCT04652830 is sponsored by Karolinska Institutet. The principal investigator is Gabriel Sandblom, Ass Prof at Karolinska Institutet. The trial plans to enroll 70 participants.